Characterization of heart rate (HR) changes during crizotinib treatment: A retrospective analysis of 1,053 ALK+ NSCLC patients.
Sai-Hong Ignatius Ou
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Yiyun Tang
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Anna Polli
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Keith D. Wilner
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Patrick Schnell
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer